Antidepressants Used by 12.7 Percent of Those Age ≥12 in U.S.

Share this content:
Antidepressants Used by 12.7 Percent of Those Age ≥12 in U.S.
Antidepressants Used by 12.7 Percent of Those Age ≥12 in U.S.

WEDNESDAY, Aug. 16, 2017 (HealthDay News) -- Antidepressant use is common among U.S. individuals aged 12 years and older, with non-Hispanic whites more likely to take antidepressants than other racial/ethnic groups, according to an August data brief published by the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics (NCHS).

Laura A. Pratt, Ph.D., from the NCHS in Hyattsville, Md., and colleagues used data from the National Health and Nutrition Examination Survey for 2011 to 2014 to examine use of antidepressants in persons aged 12 years and older.

The researchers found that 12.7 percent of individuals (8.6 percent of males and 16.5 percent of females) took antidepressants in the past month during 2011 to 2014. Non-Hispanic whites were more likely to take antidepressant medications than any other race and Hispanic-origin groups, among both males and females. Of those who took antidepressant medications, one-fourth had done so for 10 years or more. There was an increase in antidepressant medication use from 1999 to 2014.

"During 2011 to 2014, about one in eight Americans aged 12 and over reported taking antidepressants in the previous month. Antidepressant use increased with age and was twice as common among females as males," the authors write. "Long-term antidepressant use was common."

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths